ArticleScientific reports2026
Simulated microgravity induces a NOX-sensitive oxidative response that is attenuated by resveratrol in human endothelial cells.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Spaceflight-associated microgravity perturbs endothelial physiology, at least in part, through oxidative stress and redox imbalance. Here, we investigated whether resveratrol protects human umbilical vein endothelial cells (HUVECs) exposed to simulated microgravity (µG) and examined whether an NADPH oxidase (NOX)-sensitive oxidative component contributes substantially to this response. Simulated µG significantly increased intracellular reactive oxygen species (ROS), enhanced protein carbonylation, disrupted glutathione homeostasis, and reduced cell viability. Pharmacological interrogation showed that diphenyleneiodonium (DPI), a broad inhibitor of flavin-dependent oxidases widely used to inhibit NOX activity, attenuated the oxidative response induced by µG. Resveratrol (1 µM) produced a comparable protective profile, reducing ROS accumulation, limiting oxidative protein damage, partially restoring the GSH/GSSG ratio, and preserving cell viability. In complementary assays, 2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo[1,2-a]pyrazin-3-one (MCLA) chemiluminescence, used here as a superoxide-associated readout, was increased under simulated µG and similarly reduced by both DPI and resveratrol. Given that NADPH oxidases (NOXs) are major endothelial sources of superoxide, the parallel inhibitory effects of DPI and resveratrol support the presence of a prominent NOX-sensitive, superoxide-associated component within the oxidative response induced by simulated µG. Collectively, these findings indicate that resveratrol attenuates simulated microgravity-induced oxidative stress and redox imbalance in endothelial cells and support its potential as a redox-active countermeasure under spaceflight-relevant conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.